ATE347561T1 - Behandlung von entzündungskrankheiten - Google Patents

Behandlung von entzündungskrankheiten

Info

Publication number
ATE347561T1
ATE347561T1 AT99949169T AT99949169T ATE347561T1 AT E347561 T1 ATE347561 T1 AT E347561T1 AT 99949169 T AT99949169 T AT 99949169T AT 99949169 T AT99949169 T AT 99949169T AT E347561 T1 ATE347561 T1 AT E347561T1
Authority
AT
Austria
Prior art keywords
grp78
bip
protein
treatment
fragment
Prior art date
Application number
AT99949169T
Other languages
English (en)
Inventor
Gabriel Stavros Panayi
Valerie Mary Corrigall
Mark Duncan Bodman-Smith
Mark Stewart Fife
Jeremy Shaun Lanchbury
Original Assignee
King S College London
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by King S College London filed Critical King S College London
Application granted granted Critical
Publication of ATE347561T1 publication Critical patent/ATE347561T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT99949169T 1998-10-09 1999-10-08 Behandlung von entzündungskrankheiten ATE347561T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9822115.3A GB9822115D0 (en) 1998-10-09 1998-10-09 Treatment of inflammatory disease

Publications (1)

Publication Number Publication Date
ATE347561T1 true ATE347561T1 (de) 2006-12-15

Family

ID=10840332

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99949169T ATE347561T1 (de) 1998-10-09 1999-10-08 Behandlung von entzündungskrankheiten

Country Status (12)

Country Link
US (1) US6995240B1 (de)
EP (1) EP1117685B1 (de)
JP (1) JP4435422B2 (de)
CN (1) CN1253470C (de)
AT (1) ATE347561T1 (de)
AU (1) AU754888B2 (de)
CA (1) CA2344590C (de)
DE (1) DE69934324T2 (de)
DK (1) DK1117685T3 (de)
ES (1) ES2277449T3 (de)
GB (1) GB9822115D0 (de)
WO (1) WO2000021995A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7094597B1 (en) * 1994-05-20 2006-08-22 The Regents Of The University Of California Vaccine compositions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis
GB0106161D0 (en) * 2001-03-13 2001-05-02 King S College London Immunomodulators
NL1019540C2 (nl) * 2001-12-11 2003-07-01 Stichting Tech Wetenschapp Werkwijze voor het detecteren van auto-antilichamen van patienten die lijden aan reumatoïde artritis, peptide en assaykit.
DE10210427A1 (de) * 2002-03-09 2003-10-09 Hans Konrad Mueller-Hermelink Humaner monoklonaler Antikörper
CA2491669A1 (en) * 2002-07-04 2004-01-15 Oncomab Gmbh Neoplasm specific antibodies and uses thereof
DE10311248A1 (de) 2003-03-14 2004-09-30 Müller-Hermelink, Hans Konrad, Prof. Dr. Humaner monoklonaler Antikörper
EP1742969A2 (de) * 2003-11-12 2007-01-17 OncoMab GmbH Verfahren zur identifizierung neoplasmaspezifischer antikörper und verwendungen davon
DE10353175A1 (de) 2003-11-14 2005-06-16 Müller-Hermelink, Hans Konrad, Prof. Dr. Humaner monoklonaler Antikörper mit fettsenkender Wirkung
EP1531162A1 (de) * 2003-11-14 2005-05-18 Heinz Vollmers Antikörper SAM-6, der spezifisch von Adenocarzinom ist, und dessen Verwendungen
DE102004015179A1 (de) * 2004-03-25 2005-10-13 Oncomab Gmbh Antigen des PM-2 Antikörpers und dessen Verwendung
JP5422203B2 (ja) * 2005-04-19 2014-02-19 キングス カレッジ ロンドン 使用
WO2008152446A2 (en) * 2006-11-27 2008-12-18 Patrys Limited Novel glycosylated peptide target in neoplastic cells
NZ586746A (en) * 2008-01-23 2012-07-27 Righospitalet Classification of individuals suffering from cardiovascular diseases according to survival prognoses as found by measuring the levels of biomarker ykl-40
US20110207917A1 (en) * 2009-02-09 2011-08-25 Patrys Limited Sam-6 variants, target and methods of use
JP2011116719A (ja) * 2009-12-07 2011-06-16 Univ Of Tokyo Ｈｌａ−ｄｒ４エピトープの同定と、関節炎治療への応用
GB201603263D0 (en) 2016-02-25 2016-04-13 King S College London Biomarkers for response to bip (rasolvir)
BR112020025398A2 (pt) * 2018-06-13 2021-04-06 Immune Regulation Limited Proteína com propriedades anti-inflamatórias
IL315962A (en) 2022-03-31 2024-11-01 Revolo Biotherapeutics Ltd The compositions and their use in methods for the treatment of intestinal inflammation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5348945A (en) * 1990-04-06 1994-09-20 Wake Forest University Method of treatment with hsp70
US5188964A (en) * 1990-04-12 1993-02-23 Board Of Regents, The University Of Texas System Method and kit for the prognostication of breast cancer patient via heat shock/stress protein determination
EP0663010B1 (de) 1992-10-02 2000-08-09 Research Corporation Technologies, Inc. Methoden der erhöhung der sekretion von überexpremierten proteinen
DE19744132A1 (de) 1997-10-01 1999-04-22 Stefan Dr Blaes Anti-Heavy Chain Binding Protein-Antikörper (Anti-BiP-Antikörper) bei rheumatoider Arthritis sowie Verfahren und Testkits zu ihrer Bestimmung in Körperflüssigkeiten
DE19817557A1 (de) * 1998-04-09 1999-10-21 Metagen Gesellschaft Fuer Genomforschung Mbh Menschliche Nukleinsäuresequenzen aus Ovartumorgewebe

Also Published As

Publication number Publication date
EP1117685B1 (de) 2006-12-06
DE69934324T2 (de) 2007-07-05
CN1253470C (zh) 2006-04-26
US6995240B1 (en) 2006-02-07
JP2003523167A (ja) 2003-08-05
EP1117685A1 (de) 2001-07-25
CN1322213A (zh) 2001-11-14
ES2277449T3 (es) 2007-07-01
CA2344590C (en) 2011-05-10
CA2344590A1 (en) 2000-04-20
AU754888B2 (en) 2002-11-28
JP4435422B2 (ja) 2010-03-17
WO2000021995A1 (en) 2000-04-20
AU6215499A (en) 2000-05-01
GB9822115D0 (en) 1998-12-02
DK1117685T3 (da) 2007-03-05
DE69934324D1 (de) 2007-01-18

Similar Documents

Publication Publication Date Title
DE69934324D1 (de) Behandlung von entzündungskrankheiten
DE69926731D1 (de) Diagnose und behandlung von aur1 und/oder aur2 verwandten erkrankungen
ATE177754T1 (de) Fragmente von prion proteinen.
EA199800104A1 (ru) Способ лечения диабета
DE59903915D1 (de) Verfahren zur frühen diagnose von carcinomen
DE69635740D1 (de) Diagnose und behandlung von mit aur-1 und/oder aur-2 assoziierten erkrankungen
ES8705633A1 (es) Un metodo de inmunoensayo
ATE232300T1 (de) Charakterisierung von polypeptiden durch spaltung und massenspektrometrie
PT738390E (pt) Substitutos para alvos e paineis de referencia melhorados
ATE135371T1 (de) Mit akuter pankreatitis assoziiertes protein, mittel zur diagnose von akuter pankreatitis
DK0500659T3 (da) Monoklonale antistoffer.
DK0948604T3 (da) Screeningsmetoder for forbindelser som binder til PYK2-polypeptidet
DE69821246D1 (de) Testverfahren für collagenpeptid
GR3031607T3 (en) Selective system scan for multizone radiotelephone subscriber units.
DK0455707T3 (da) Blodkoagulationsfaktor betaXIIa monoklonalt antistof og immunassay
NO982588D0 (no) FremgangsmÕte for diagnose og behandling av plate epizelkarsinom
DK0495907T3 (da) cDNA-fragment, som koder for alfa-interferon-receptorgenet, og fremgangsmåde til fremstilling af et tilsvarende protein
DE69734890D1 (de) Rdgb-proteine
ATE500273T1 (de) Methoden zur analyse von antikörperdisulfidisomere
SE9602234D0 (sv) A novel diagnostic method utilizing ECP, and reagents to be used in the methods
NO962596L (no) Nytt tumorsupressorgen
DK1171157T3 (da) Anvendelse af glucose-6-phosphat-isomerase og antistoffer derimod til diagnosticering og behandling af arthritis, og test for anti-arthritis-forbindelser
DE59813125D1 (de) Srcr domäne-enthaltendes protein
DE60231845D1 (de) Diagnoseverfahren für proteinprofilierung
ATE369381T1 (de) NUKLEARES PROTEIN ßSHOCAß - EINE KOMPONENTE DES WNT SIGNALTRANSDUKTIONSWEGES

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties